CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced robust lobe-specific changes in white ...

Researchers suggest that as well as serving as a biomarker, brain iron may become a future therapeutic target.

The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson's disease, according to a study ...

A long-term brain imaging study in aging adults showed faster rates of atrophy in certain brain structures to be associated with the risk of developing mild cognitive impairment (MCI). While some ...

Anti-amyloid-beta (anti-Aβ) drugs, which are used in the management of Alzheimer's disease (AD), have the potential to compromise long-term brain health by accelerating brain atrophy, a comprehensive ...

Gamified exercise training improves hippocampal volume and cognitive performance in mild neurocognitive disorders, offering ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed blood biomarker data from 420 active and retired athletes and 52 controls. Boxers had the ...

An enlargement of the brain ventricle might set off alarm bells in a neurologist's office. And yet, in people on anti-amyloid immunotherapy, it occurs quite commonly. Is this a red flag, or an ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with ...